id int64 0 10k | problem stringlengths 9.93k 17.3k | answer stringlengths 3.19k 7.24k | solution stringlengths 1.1k 30.8k | messages listlengths 2 2 |
|---|---|---|---|---|
0 | You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients.
You are given three patient descriptions and their outcome (whether they died or not).
Your **target patient** is the third and final patient.
The two first patient descriptions are **example patients**.
These pateitns are s... |
### **Clinical Analysis and Reasoning for Target Patient Outcome**
The target patient’s fatal outcome stems from a **high-risk convergence of untreated stage 3 hypertension, smoking-induced endothelial injury, and thromboembolic risk from atrial fibrillation (AFib)**, compounded by the absence of guideline-directed... | <think>
Okay, let's tackle this. I need to figure out why the target patient died using the two examples provided. Let me start by analyzing all three patients' details.
First, Example Patient 1: Alive. He's 64.5 years old, overweight (BMI 27.8), smokes 20 cigs/day, has AFib. His BP is elevated (132 systolic) but not ... | [
{
"content": "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou are given three patient descriptions and their outcome (whether they died or not).\nYour **target patient** is the third and final patient.\nThe two first patient descriptions are **example patients... |
1 | You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients.
You are given three patient descriptions and their outcome (whether they died or not).
Your **target patient** is the third and final patient.
The two first patient descriptions are **example patients**.
These pateitns are s... |
**Clinical Analysis and Explanation of Target Patient Outcome**
The target patient’s fatal outcome arises from the synergistic interplay of **untreated stage 2 hypertension**, **severe mixed dyslipidemia**, and **ethnicity-mediated risk amplification**, compounded by advanced age. To contextualize this, we must co... | <think>
Okay, let's tackle this. The target patient died, and I need to explain why based on the two examples. Let me start by reviewing the example patients.
Example Patient 1: Alive. She's 55, Black female, BMI 25 (overweight). Stage 1 hypertension (143 mmHg), no meds. No diabetes, CKD, or dyslipidemia. Inflammatory... | [
{
"content": "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou are given three patient descriptions and their outcome (whether they died or not).\nYour **target patient** is the third and final patient.\nThe two first patient descriptions are **example patients... |
2 | You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients.
You are given three patient descriptions and their outcome (whether they died or not).
Your **target patient** is the third and final patient.
The two first patient descriptions are **example patients**.
These pateitns are s... |
The target patient’s paradoxical profile—marked by adiposity (BMI 29.1 kg/m²) juxtaposed with a hypolipidemic state (total cholesterol 2.556 mmol/L, triglycerides 0.423 mmol/L) and absence of traditional cardiometabolic risk factors—presents a unique clinical challenge. To reconcile her outcome (death) with the examp... | <think>
Okay, let's tackle this. The target patient died, and I need to figure out why by comparing her to the two example patients.
First, let's recap the examples. Patient 1 was alive despite having metabolic issues: overweight, atherogenic dyslipidemia (low HDL, high triglycerides), borderline glucose, and some in... | [
{
"content": "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou are given three patient descriptions and their outcome (whether they died or not).\nYour **target patient** is the third and final patient.\nThe two first patient descriptions are **example patients... |
3 | You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients.
You are given three patient descriptions and their outcome (whether they died or not).
Your **target patient** is the third and final patient.
The two first patient descriptions are **example patients**.
These pateitns are s... |
The target patient’s fatal outcome arises from a confluence of modifiable risk factors synergizing with age and smoking intensity, culminating in a high-risk atherosclerotic cardiovascular disease (ASCVD) phenotype. Below is the structured analysis:
---
### **Key Risk Factor Comparison**
| **Parameter** ... | <think>
Okay, let's start by carefully comparing the three patients. The target patient is the third one, and I need to figure out why they died based on the examples provided.
First, looking at Example Patient 1 who survived. He's 58 with a higher BMI (30.4) indicating Class I obesity. His systolic BP is 149, stage ... | [
{
"content": "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou are given three patient descriptions and their outcome (whether they died or not).\nYour **target patient** is the third and final patient.\nThe two first patient descriptions are **example patients... |
4 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s fatal outcome arises from a convergence of **untreated high-risk cardiov(...TRUNCATED) | "<think>\nOkay, let's tackle this. The target patient is the third one, and we need to figure out wh(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
5 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s fatal outcome arises from a convergence of **untreated atherogenic dysli(...TRUNCATED) | "<think>\nOkay, let's tackle this. The target patient died, and I need to explain why by comparing h(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
6 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s fatal outcome arises from a confluence of **untreated high-risk cardiova(...TRUNCATED) | "<think>\nOkay, let's tackle this. The target patient died, and I need to explain why by comparing h(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
7 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s mortality is best understood through a comparative analysis of the three(...TRUNCATED) | "<think>\nOkay, let's tackle this. The target patient died, and I need to explain why based on the t(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
8 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s fatal outcome arises from a confluence of *unmanaged cardiovascular risk(...TRUNCATED) | "<think>\nOkay, let's dive into analyzing these three patients. The goal is to figure out why the ta(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
9 | "You are a powerful AI with expertise in medicine with a specialty in cardiovascular patients. \nYou(...TRUNCATED) | "\n\nThe target patient’s fatal outcome arises from a confluence of **untreated, severe residual c(...TRUNCATED) | "<think>\nOkay, let's tackle this. The target patient died, and I need to explain why by comparing h(...TRUNCATED) | [{"content":"You are a powerful AI with expertise in medicine with a specialty in cardiovascular pat(...TRUNCATED) |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 11